Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2026-01-28 @ 1:59 PM
Study NCT ID:
NCT04466150
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-01-08
First Post:
2020-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Sponsor:
Organization: